openPR Logo
Press release

Investigation for Long-Term Investors in shares of Lipocine Inc. (NASDAQ: LPCN) announced

03-24-2020 04:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Lipocine Inc. (NASDAQ: LPCN) shares.

An investigation on behalf of current long term investors in Lipocine Inc. (NASDAQ: LPCN) shares.

An investigation was announced for current long-term investors in shares of Lipocine Inc. (NASDAQ: LPCN) concerning potential breaches of fiduciary duties by certain directors of Lipocine Inc. was announced.

Investors who are current long term investors in Lipocine Inc. (NASDAQ: LPCN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: LPCN stocks follows a lawsuit filed against Lipocine Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: LPCN stocks, concerns whether certain Lipocine directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of Utah the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the results from Lipocine's clinical studies of TLANDO were insufficient to demonstrate the drug's efficacy, that accordingly, Lipocine's third NDA for TLANDO was highly likely to be found deficient by the FDA, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Long-Term Investors in shares of Lipocine Inc. (NASDAQ: LPCN) announced here

News-ID: 1982414 • Views: 336

More Releases from Shareholders Foundation

Deadline on Nov. 3rd coming up in Lawsuit for Investors in shares of Coty Inc. ( …
The Shareholders Foundation announced that a deadline is coming up on November 3, 2020 in the lawsuit filed for certain investors of Coty Inc. (NYSE: COTY) over alleged securities laws violations by Coty Inc. Investors who purchased shares of Coty Inc. (NYSE: COTY) have certain options and there are strict and short deadlines running. Deadline: November 3, 2020. NYSE: COTY stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investigation announced for Long-Term Investors in shares of Insperity, Inc. (NY …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Insperity, Inc. Investors who are current long term investors in Insperity, Inc. (NYSE: NSP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for investors in NYSE: NSP stocks follows a lawsuit filed against Insperity, Inc. over alleged securities laws
Lawsuit filed for Investors in shares of Evolus, Inc. (NASDAQ: EOLS)
An investor, who purchased shares of Evolus, Inc. (NASDAQ: EOLS), filed a lawsuit over alleged violations of Federal Securities Laws by Evolus, Inc. Investors who purchased shares of Evolus, Inc. (NASDAQ: EOLS) have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2020. NASDAQ: EOLS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. An International Trade Commission judge issued a
Investigation announced for Investors in shares of Citigroup Inc. (NYSE: C)
An investigation was announced over potential securities laws violations by Citigroup Inc. and certain of its directors and officers in connection with certain financial statements was announced. Investors who purchased shares of Citigroup Inc. (NYSE: C), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Citigroup

All 5 Releases


More Releases for Lipocine

Latest Study on Targeted Delivery Drugs Market 2020 and Brief Analysis of Top Co …
Global Targeted Delivery Drugs Market Industry research report covers the industry overview with Market Size, Share, Growth, futuristic cost, revenue, demand and supply data. Targeted Delivery Drugs Industry research analysts provide an elaborate description of the value chain and its distributor analysis The Global Targeted Delivery Drugs Market -study provides comprehensive data which enhances the understanding, scope and application of this report. Get Sample Copy of This Report @ https://www.orianresearch.com/request-sample/1589596 Global Targeted
Sexual Wellness Market 2020- Analysis And In-Depth Research On Market Size, Tren …
Complete study of the global Sexual Wellness market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Sexual Wellness industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also
Trending Report : Male Hypogonadism Market Is Estimated To Reach $3,350 Million …
Male hypogonadism is a condition in which the body does not produce enough testosterone - a hormone that plays a key role in male growth and development during puberty - or has poor sperm production capacity or both .Male Hypogonadism Market Is Estimated To Reach $3,233 Million From $2,594 Million And Is Supported By a CAGR Of 3% During The Forecast Period Get Sample @ https://www.researchreportsinc.com/sample-request?id=31794 List of Key Players
Future of Female Contraceptive Products Market – A comprehensive study by Key …
MarketResearchNest.com adds “Global Female Contraceptive Products Industry Market Research Report” new report to its research database. The report spread across 103 pages with multiple tables and figures in it. This report studies the Female Contraceptive Products market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers.
Global Premature Labor Treatment Market Size 2018-2023 ObsEva, Lipocine, AMAG Ph …
A market study "Global Premature Labor Treatment Market" examines the performance of the Premature Labor Treatment market 2018. It encloses an in-depth Research of the Premature Labor Treatment market state and the competitive landscape globally. This report analyzes the potential of Premature Labor Treatment market in the present and the future prospects from various angles in detail. The Global Premature Labor Treatment Market 2018 report includes Premature Labor Treatment market Revenue,
At a CAGR of 2%, Global Topical Contraceptive Market to rise over Forecast perio …
Topical contraceptives are contraceptive patches that release hormones, estrogen, and progestin to prevent pregnancies. They work in a similar manner as oral contraceptives. Various temporary and permanent contraceptive methods and devices for women are available in the market. Permanent methods such as sterilization are considered the most effective as they eliminate the chances of pregnancy. The global topical contraceptive market to grow at a CAGR of 2% during the period 2017-2021.